| dc.creator | Florou Z., Zigra M., Kartalidis P., Tsilipounidaki K., Papadamou G., Belia A., Fthenakis G.C., Petinaki E. | en |
| dc.date.accessioned | 2023-01-31T07:38:11Z | |
| dc.date.available | 2023-01-31T07:38:11Z | |
| dc.date.issued | 2021 | |
| dc.identifier | 10.3390/microorganisms9061263 | |
| dc.identifier.issn | 20762607 | |
| dc.identifier.uri | http://hdl.handle.net/11615/71626 | |
| dc.description.abstract | The objective of the present study was to evaluate the true positivity among people, whose results of initial testing of nasopharyngeal swabs (NPS) showed a very low viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Seventy-seven people detected with low viral loads of SARs-CoV-2 in nasopharyngeal samples (Ct ≥ 35) were enrolled in the study. For this purpose, a second NPS was collected for rRT-PCR (real-time reverse transcription polymerase chain reaction) combined with a pair of serum samples for detection of anti-nucleocapsid (anti-N) and anti-spike (anti-S) antibodies. In 8 people, subsequent examinations indicated an increase in viral loads, thereafter, followed by an increase of anti-N and anti-S antibodies, findings compatible with an early stage of COVID-19 infection. In 9 people, who already had increased anti-N antibodies, subsequent examination showed a decrease or absence of viral load and an increase in antibodies, indicative of a late stage of COVID-19 infection. In 60 people, subsequent examination showed absence of infection (as indicated by absence of viral load and antibodies). We propose that the combination of a second NPS and one serum-specimen, both taken three days after the first NPS, helps significantly to avoid false-positive results. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | en |
| dc.language.iso | en | en |
| dc.source | Microorganisms | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108122931&doi=10.3390%2fmicroorganisms9061263&partnerID=40&md5=623f736e5d310013fa794c3bd80718a4 | |
| dc.subject | MDPI AG | en |
| dc.title | Combination of rrt-pcr and anti-nucleocapsid/anti-spike antibodies to characterize specimens with very low viral sars-cov-2 load: A real-life experience | en |
| dc.type | journalArticle | en |